These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1364974)

  • 1. HLA antibodies in renal transplant candidates.
    Lenhartová E; Lenhart K; Bártová A; Loucková I
    Acta Univ Palacki Olomuc Fac Med; 1992; 134():81-3. PubMed ID: 1364974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I.
    Süsal C; Opelz G
    Hum Immunol; 2004 Aug; 65(8):810-6. PubMed ID: 15336782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome.
    Praticò-Barbato L; Conca R; Magistroni P; Leonardi G; Oda A; Rosati F; Leone E; Tacconella M; Roggero S; Segoloni GP; Amoroso A
    Transpl Immunol; 2008 Jul; 19(3-4):238-43. PubMed ID: 18675725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class I antibodies in patients awaiting kidney transplantation and the association with renal graft survival.
    Wu HH; Tien YC; Huang CI; Chiang YJ; Chu SH; Lai PC
    Transplant Proc; 2008 Sep; 40(7):2191-4. PubMed ID: 18790188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HLA antibody profile of Turkish patients with end-stage renal disease.
    Karahan GE; Seyhun Y; Oguz F; Kekik C; Onal E; Caliskan Y; Bakkaloglu H; Yazici H; Turkmen A; Aydin AE; Sever MS; Eldegez U; Carin MN
    Transplant Proc; 2009 Nov; 41(9):3651-4. PubMed ID: 19917361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-HLA antibodies in nephropathic patients].
    Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
    G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
    Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD
    Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
    Proust B; Kennel A; Ladrière M; Kessler M; Perrier P
    Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of posttransplant anti-HLA antibody on outcome of renal transplantation.
    Vareesangthip K; Assavisaraporn W; Bintaprasit W; Vejbaesya S
    Transplant Proc; 2004 Sep; 36(7):2048-50. PubMed ID: 15518741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates.
    Arnold ML; Dechant M; Doxiadis II; Spriewald BM
    Tissue Antigens; 2008 Jul; 72(1):60-6. PubMed ID: 18588575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of donor cell type on complement-dependent cytotoxicity crossmatch outcome for patients immunized against HLA class-II antigens.
    Arnold ML; Ensminger SM; Doxiadis II; Spriewald BM
    Exp Clin Transplant; 2008 Mar; 6(1):1-6. PubMed ID: 18405238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of nodular endocardial infiltrates (Quilty lesions) to survival, patient age, anti-HLA antibodies, and coronary artery disease following heart transplantation.
    Chu KE; Ho EK; de la Torre L; Vasilescu ER; Marboe CC
    Cardiovasc Pathol; 2005; 14(4):219-24. PubMed ID: 16009321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody.
    Halloran PF; Schlaut J; Solez K; Srinivasa NS
    Transplantation; 1992 Mar; 53(3):550-5. PubMed ID: 1549846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.